Jefferies Lifts Target on Celldex Therapeutics (CLDX) to $9 on Compelling CDX-011 OS Data
Tweet Send to a Friend
Jefferies boosted its price target on Buy-rated Celldex Therapeutics (NASDAQ: CLDX) from $7 to $9.
The firm comments, "CLDX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm comments, "CLDX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
